Artery is proud to inform that the ATI-CS-001 study (NCT05965414) has been approved by regulatory authorities, ethics committee with screening commencing November 1, 2023.

Artery is proud to inform that the ATI-CS-001 study (NCT05965414) has been approved by regulatory authorities, ethics committee with screening commencing November 1, 2023. For more information, please visit https://clinicaltrials.gov/study/NCT05965414. ​

The release as fetched from its publisher. arterytx.com ↗